PSMD9 antibody
Quick Overview for PSMD9 antibody (ABIN111067)
Target
See all PSMD9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognizes the 20S subcomplex within the 26S hetero-oligomeric protein complex and the free cytosolic form of 20S cylinder particles, the epitope is resistant to formaldehyde fixation (up to 4 %) Antigen Recognized in Species and Cultured Cell Lines (tested so far): Xenopus laevis, XLKE-A6 (Xenopus laevis), PLC (human), RVF (rat), Ptk2 (rat, kangaroo)
-
Purification
- Hybridoma culture supernatant
-
Immunogen
- Nuclear 26S complexes of Xenopus laevis oocytes
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Immunofluorescence microscopy: Ready to use, 20 - 30 min at RT, longer incubation mayresult in loss of soluble antigen. Western Blot: 1: 100 when using the ECL method. Immunoprecipitation (Ascites*). Affinity chromatography (Ascites*).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C.
-
-
- PSMD9 (Proteasome (Prosome, Macropain) 26S Subunit, Non-ATPase, 9 (PSMD9))
-
Alternative Name
- PSMD9
-
Background
- Synonyms: 26S proteasome non-ATPase regulatory subunit 9, 26S proteasome regulatory subunit p27
-
Gene ID
- 5715
-
NCBI Accession
- NP_002804
-
UniProt
- O00233
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Mitotic G1-G1/S Phases, DNA Replication, Synthesis of DNA, Ubiquitin Proteasome Pathway
Target
-